Vrati S, Kerr P J, Weir R C, Dalgarno L
Division of Biochemistry and Molecular Biology, Faculty of Science, Australian National University, Canberra, Australia.
J Virol. 1996 Mar;70(3):1745-50. doi: 10.1128/JVI.70.3.1745-1750.1996.
Previously we identified the locations of three neutralization epitopes (a, b1 and b2) of Ross River virus (RRV) by sequencing a number of variants resistant to monoclonal antibody neutralization which were found to have single amino acid substitutions in the E2 protein (S. Vrati, C.A. Fernon, L. Dalgarno, and R.C. Weir, Virology 162:346-353, 1988). We have now studied the biological properties of these variants in BHK cells and their virulence in mice. While variants altered in epitopes a and/or b1 showed no difference, variants altered in epitope b2, including a triple variant altered in epitopes a, b1, and b2, showed rapid penetration but retarded kinetics of growth and RNA and protein synthesis in BHK cells compared with RRV T48, the parent virus. Variants altered in epitopes a and/or b1 showed no change in mouse virulence. However, two of the six epitope b2 variants examined had attenuated mouse virulence. They had a four- to fivefold-higher 50% lethal dose (LD50), although no change in the average survival time of infected mice was observed. These variants grew to titers in mouse tissues similar to those of RRV T48. The ID50 of the triple variant was unchanged, but infected mice had an increased average survival time. This variant produced lower levels of viremia in infected mice. On the basis of these findings we propose that both the receptor binding site and neutralization epitopes of RRV are nearby or in the same domain of the E2 protein.
先前我们通过对一些对单克隆抗体中和具有抗性的变异株进行测序,确定了罗斯河病毒(RRV)三个中和表位(a、b1和b2)的位置,发现这些变异株在E2蛋白中存在单个氨基酸替换(S. 弗拉蒂、C.A. 费农、L. 达尔加诺和R.C. 韦尔,《病毒学》162:346 - 353,1988年)。我们现在研究了这些变异株在BHK细胞中的生物学特性及其在小鼠中的毒力。虽然表位a和/或b1发生改变的变异株没有差异,但表位b2发生改变的变异株,包括在表位a、b1和b2均发生改变的三重变异株,与亲本病毒RRV T48相比,在BHK细胞中显示出快速穿透但生长动力学以及RNA和蛋白质合成延迟。表位a和/或b1发生改变的变异株在小鼠毒力方面没有变化。然而,所检测的六个表位b2变异株中有两个的小鼠毒力减弱。它们的50%致死剂量(LD50)高四到五倍,尽管未观察到感染小鼠的平均存活时间有变化。这些变异株在小鼠组织中的滴度与RRV T48相似。三重变异株的半数感染剂量(ID50)未改变,但感染小鼠的平均存活时间增加。该变异株在感染小鼠中产生的病毒血症水平较低。基于这些发现,我们提出RRV的受体结合位点和中和表位都在E2蛋白的附近或同一结构域中。